201 related articles for article (PubMed ID: 32906814)
21. Stroma-derived matrix metalloproteinase (MMP)-2 promotes membrane type 1-MMP-dependent tumor growth in mice.
Taniwaki K; Fukamachi H; Komori K; Ohtake Y; Nonaka T; Sakamoto T; Shiomi T; Okada Y; Itoh T; Itohara S; Seiki M; Yana I
Cancer Res; 2007 May; 67(9):4311-9. PubMed ID: 17483344
[TBL] [Abstract][Full Text] [Related]
22. Expression and Function of a Disintegrin and Metalloproteinases in Cancer-Associated Fibroblasts of Colorectal Cancer.
Mochizuki S; Ao T; Sugiura T; Yonemura K; Shiraishi T; Kajiwara Y; Okamoto K; Shinto E; Okada Y; Ueno H
Digestion; 2020; 101(1):18-24. PubMed ID: 31722362
[TBL] [Abstract][Full Text] [Related]
23. microRNA-1298 inhibits the malignant behaviors of breast cancer cells via targeting ADAM9.
Chen W; Lu Q; Li S; Zhang X; Xue X
Biosci Rep; 2020 Dec; 40(12):. PubMed ID: 33146718
[TBL] [Abstract][Full Text] [Related]
24. ADAM9 silencing inhibits breast tumor cells transmigration through blood and lymphatic endothelial cells.
Micocci KC; Moritz MN; Lino RL; Fernandes LR; Lima AG; Figueiredo CC; Morandi V; Selistre-de-Araujo HS
Biochimie; 2016; 128-129():174-82. PubMed ID: 27554339
[TBL] [Abstract][Full Text] [Related]
25. Identification of the Cell-Surface Protease ADAM9 as an Entry Factor for Encephalomyocarditis Virus.
Baggen J; Thibaut HJ; Hurdiss DL; Wahedi M; Marceau CD; van Vliet ALW; Carette JE; van Kuppeveld FJM
mBio; 2019 Aug; 10(4):. PubMed ID: 31409686
[TBL] [Abstract][Full Text] [Related]
26. Changes in gene expression of matrix constituents with respect to passage of ligament and tendon fibroblasts.
Almarza AJ; Augustine SM; Woo SL
Ann Biomed Eng; 2008 Dec; 36(12):1927-33. PubMed ID: 18807189
[TBL] [Abstract][Full Text] [Related]
27. Characterization of the catalytic properties of the membrane-anchored metalloproteinase ADAM9 in cell-based assays.
Maretzky T; Swendeman S; Mogollon E; Weskamp G; Sahin U; Reiss K; Blobel CP
Biochem J; 2017 Apr; 474(9):1467-1479. PubMed ID: 28264989
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA‑302a suppresses cell proliferation, migration and invasion in osteosarcoma by targeting ADAM9.
Yang X; Cui Y; Yang F; Sun C; Gao X
Mol Med Rep; 2017 Sep; 16(3):3565-3572. PubMed ID: 28713950
[TBL] [Abstract][Full Text] [Related]
29. Soft matrices inhibit cell proliferation and inactivate the fibrotic phenotype of deep endometriotic stromal cells in vitro.
Matsuzaki S; Canis M; Pouly JL; Darcha C
Hum Reprod; 2016 Mar; 31(3):541-53. PubMed ID: 26762314
[TBL] [Abstract][Full Text] [Related]
30. SPARC endogenous level, rather than fibroblast-produced SPARC or stroma reorganization induced by SPARC, is responsible for melanoma cell growth.
Prada F; Benedetti LG; Bravo AI; Alvarez MJ; Carbone C; Podhajcer OL
J Invest Dermatol; 2007 Nov; 127(11):2618-28. PubMed ID: 17625595
[TBL] [Abstract][Full Text] [Related]
31. The pleiotropic roles of ADAM9 in the biology of solid tumors.
Oria VO; Lopatta P; Schilling O
Cell Mol Life Sci; 2018 Jul; 75(13):2291-2301. PubMed ID: 29550974
[TBL] [Abstract][Full Text] [Related]
32. RNAi-mediated A disintegrin and metalloproteinase 9 gene silencing inhibits the tumor growth of non-small lung cancer in vitro and in vivo.
Chang L; Gong F; Cui Y
Mol Med Rep; 2015 Jul; 12(1):1197-204. PubMed ID: 25778452
[TBL] [Abstract][Full Text] [Related]
33. Glycosaminoglycan Modification of Decorin Depends on MMP14 Activity and Regulates Collagen Assembly.
Daquinag AC; Gao Z; Fussell C; Sun K; Kolonin MG
Cells; 2020 Dec; 9(12):. PubMed ID: 33317052
[TBL] [Abstract][Full Text] [Related]
34. Decorin-expressing adenovirus decreases collagen synthesis and upregulates MMP expression in keloid fibroblasts and keloid spheroids.
Lee WJ; Ahn HM; Roh H; Na Y; Choi IK; Lee JH; Kim YO; Lew DH; Yun CO
Exp Dermatol; 2015 Aug; 24(8):591-7. PubMed ID: 25865370
[TBL] [Abstract][Full Text] [Related]
35. The disintegrin domain of ADAM9: a ligand for multiple beta1 renal integrins.
Mahimkar RM; Visaya O; Pollock AS; Lovett DH
Biochem J; 2005 Jan; 385(Pt 2):461-8. PubMed ID: 15361064
[TBL] [Abstract][Full Text] [Related]
36. ADAM9 is involved in pathological retinal neovascularization.
Guaiquil V; Swendeman S; Yoshida T; Chavala S; Campochiaro PA; Blobel CP
Mol Cell Biol; 2009 May; 29(10):2694-703. PubMed ID: 19273593
[TBL] [Abstract][Full Text] [Related]
37. Lumican delays melanoma growth in mice and drives tumor molecular assembly as well as response to matrix-targeted TAX2 therapeutic peptide.
Jeanne A; Untereiner V; Perreau C; Proult I; Gobinet C; Boulagnon-Rombi C; Terryn C; Martiny L; Brézillon S; Dedieu S
Sci Rep; 2017 Aug; 7(1):7700. PubMed ID: 28794454
[TBL] [Abstract][Full Text] [Related]
38. Stromal PTEN Regulates Extracellular Matrix Organization in the Mammary Gland.
Jones CE; Hammer AM; Cho Y; Sizemore GM; Cukierman E; Yee LD; Ghadiali SN; Ostrowski MC; Leight JL
Neoplasia; 2019 Jan; 21(1):132-145. PubMed ID: 30550871
[TBL] [Abstract][Full Text] [Related]
39. MicroRNA‑543 inhibits proliferation, invasion and induces apoptosis of glioblastoma cells by directly targeting ADAM9.
Ji T; Zhang X; Li W
Mol Med Rep; 2017 Nov; 16(5):6419-6427. PubMed ID: 28849046
[TBL] [Abstract][Full Text] [Related]
40. Tamoxifen induces pleiotrophic changes in mammary stroma resulting in extracellular matrix that suppresses transformed phenotypes.
Hattar R; Maller O; McDaniel S; Hansen KC; Hedman KJ; Lyons TR; Lucia S; Wilson RS; Schedin P
Breast Cancer Res; 2009; 11(1):R5. PubMed ID: 19173736
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
